Neurophysiological Basis of Acupuncture-Induced Analgesia: An Updated Review
Leung · Journal of Acupuncture and Meridian Studies · 2012
Evidence Level
STRONGOBJECTIVE
To review the neurophysiologic mechanisms of acupuncture-induced analgesia based on current scientific evidence
FOCUS
Neurotransmitter systems, descending inhibitory pathways, and neural plasticity
COVERAGE
Evidence from 1970 through 2012
POINTS
ST-36 (Zusanli 足三里) and other points with dense innervation
🔬 Study Design
Literature review
n=0
Analysis of studies on neuromechanisms
📊 Results in numbers
Low frequency (2 Hz) releases enkephalins
High frequency (100 Hz) releases dynorphins
Needle-removal force at acupoints
Total principal acupoints
Principal meridians
Percentage highlights
📊 Outcome Comparison
Endogenous opioid release
This study shows that acupuncture works through several well-defined brain mechanisms, including the release of natural pain-relieving substances (endorphins) and the activation of pain inhibitory systems. The sensation of De-Qi 得氣 (a special sensation during treatment) is fundamental to therapeutic efficacy.
Article summary
Plain-language narrative summary
This comprehensive review examines the neurophysiologic foundations of acupuncture-induced analgesia, consolidating decades of scientific research to explain how this ancient therapeutic modality produces pain relief through well-defined biomedical mechanisms. Acupuncture, with origins that go back 10,000 years BCE in China, involves the insertion of needles at specific points on the body to achieve therapeutic effects. According to Traditional Chinese Medicine, acupuncture modulates the flow of Qi 氣 and Xue 血 through the meridians to re-establish homeostasis of the principal organs, governed by the laws of Yin-Yang 陰陽 and the Five Elements 五行. The study reveals that acupuncture points are anatomically distinct sites, characterized by higher density of innervation, more compact connective tissue, and elevated concentrations of TRPV1 receptors.
Research demonstrates that 18% more force is required to remove a needle from an acupoint compared with control points, suggesting differentiated tissue organization. The 365 principal points are distributed along 12 meridians that cover the entire body. The review presents evidence that different frequencies of electroacupuncture activate distinct neurotransmitter systems: 2 Hz primarily stimulates myelinated A-beta fibers and releases enkephalins, beta-endorphins, and endomorphins, whereas 100 Hz activates smaller A-delta and C fibers, selectively releasing dynorphins. The De-Qi 得氣 phenomenon, described as a sensation of pressure or dull ache during treatment, is fundamental for analgesic efficacy.
Functional neuroimaging studies demonstrate that De-Qi activates anticorrelated brain networks, including deactivation of the default mode network and activation of somatosensory regions. Acupuncture analgesia operates through multiple integrated neurobiologic mechanisms. First, needle insertion at acupoints activates mechanoreceptors, sending afferent signals through ventrolateral tracts to brain nuclei that modulate pain perception via descending inhibitory pathways. Second, there is release of endogenous opioid peptides that act on mu-opioid and N/OFQ receptors, demonstrated by positron emission tomography studies showing increased opioid receptor binding in the cingulate cortex, caudate nucleus, and amygdala.
Third, there is modulation of the noradrenergic and serotonergic systems, with evidence that alpha-2 adrenergic receptors suppress nociceptive signaling while alpha-1 receptors facilitate it. The serotonergic system also participates, with 5-HT1A and 5-HT3 receptors mediating analgesia. Fourth, acupuncture modulates the glutamatergic NMDA/AMPA/kainate system, crucial in spinal nociception processing and central sensitization. Studies show that NMDA receptor blockers potentiate the analgesic effects of electroacupuncture.
Fifth, inflammatory mediators produced by local microtrauma from the needle stimulate unmyelinated C fibers, activating diffuse noxious inhibitory control (DNIC), which enhances the general descending inhibitory control of nociception. Sixth, with repeated treatments, neural plasticity develops in the spinal dorsal horn through the interaction between long-term potentiation and depression of C-fiber potentials, providing lasting relief. The review also addresses the phenomenon of nonresponsiveness to acupuncture, present in approximately one in seven patients. Research has identified that nonresponders show greater expression of cholecystokinin octapeptide (CCK-8) and its receptors in the hypothalamus, a substance with anti-opioid activity that antagonizes electroacupuncture analgesia.
Clinical studies support these mechanisms, demonstrating reduced demand for opioid medications in chronic pain patients treated with electroacupuncture, in addition to proven efficacy in postoperative pain control across several surgical specialties. The clinical implications are significant, as this mechanistic understanding provides a solid scientific basis for the use of acupuncture in pain management, facilitating its integration into conventional medicine and the optimization of treatment protocols.
Strengths
- 1Comprehensive review of multiple neurobiologic mechanisms
- 2Integration of preclinical and clinical evidence
- 3Solid foundation for the scientific understanding of acupuncture
- 4Identification of biomarkers of responsiveness
Limitations
- 1Lack of standardization in research protocols
- 2Limited confirmatory clinical studies
- 3Need for further research on individual variability
- 4Absence of long-term safety data
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
Leung's review consolidates decades of neuroscience applied to acupuncture into a mechanistic map that every physician working with chronic pain should know. For the clinician who routinely deals with patients refractory to conventional analgesics or unable to use long-term opioids, understanding that electroacupuncture at 2 Hz mobilizes enkephalins, beta-endorphins, and endomorphins — while 100 Hz selectively recruits dynorphins — transforms the choice of frequency from a technical detail into a conscious pharmacologic decision. In perioperative management practice, the demonstrated reduction in postoperative opioid demand positions electroacupuncture as an anesthetic adjuvant with a solid neurochemical basis. Oncology patients, polymedicated older adults, and individuals with prior opioid dependence represent populations that benefit directly from this non-pharmacologic arsenal, grounded in mechanistic evidence that facilitates dialogue with colleagues from other specialties.
▸ Notable Findings
Two findings stand out in this review. The first is the characterization of acupoints as anatomically distinct structures — greater density of innervation, more compact connective tissue, elevated concentrations of TRPV1 receptors, and 18% greater needle-removal force compared with control points — which provides concrete morphologic substrate for the topographic specificity that classical medicine has always postulated. The second is the elucidation of the De-Qi 得氣 phenomenon in terms of functional neuroimaging: the sensation of dull pressure or distension during treatment corresponds to anticorrelated patterns of cortical activation, with deactivation of the default mode network and recruitment of somatosensory regions. The identification of cholecystokinin octapeptide (CCK-8) as a biomarker of nonresponsiveness — present in approximately one in seven patients — opens a concrete diagnostic perspective to stratify treatment candidates before initiating a therapeutic series.
▸ From My Experience
At the Pain Center of HC-FMUSP (Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo), the choice of electroacupuncture frequency stopped being empirical for us long ago. Patients with neuropathic pain and central hypersensitization usually respond better to alternating 2 Hz and 100 Hz — a protocol called dense-disperse — which simultaneously recruits the two neuropeptide profiles described in this review. I have observed measurable clinical response between the third and fifth session in most cases of chronic musculoskeletal pain, with consolidation between eight and twelve sessions until the maintenance plateau. The nonresponder profile described by Leung corresponds to what we see in the clinic: anxious patients, with a high state of alertness and a history of inadequate response to weak opioids, frequently obtain no benefit in the first sessions. In these cases, we combine autonomic nervous system regulation techniques and review baseline medication before concluding refractoriness. Combination with motor physical therapy potentiates and prolongs analgesia, something we empirically perceived long before spinal plasticity entered the vocabulary of pain neuroscience.
Full original article
Read the full scientific study
Journal of Acupuncture and Meridian Studies · 2012
DOI: 10.1016/j.jams.2012.07.017
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories